School personnel information

写真b

Koyama Shouhei


Keyword

Cancer Immunology

Organization 【 display / non-display

  • 2015.06.01 - 2018.03.31, Immunology Frontier Research Center, Assistant Professor

  • 2018.04.01 - 2020.03.31, Division of Medicine, Graduate School of Medicine, Assistant Professor

  • 2020.04.01 - , Division of Medicine, Graduate School of Medicine, Assistant Professor

 

Academic Papers 【 display / non-display

  • Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients., Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A., JCI Insight. ,3(19), 2018.10, Papers

  • Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors., Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL, Dranoff G, Curry WT, Fecci PE., Nat Med.,24(9), 2018.09, Papers

  • Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging., Yingji Jin, Yoshito Takeda, Yasushi Kondo, Lokesh P Tripathi, Sujin Kang, Hikari Takeshita, Hanako Kuhara, Yohei Maeda, Masayoshi Higashiguchi, Kotaro Miyake, Osamu Morimura, Taro Koba, Yoshitomo Hayama, Shohei Koyama, Kaori Nakanishi, Takeo Iwasaki, Satoshi Tetsumoto, Kazuyuki Tsujino, Muneyoshi Kuroyama, Kota Iwahori, Haruhiko Hirata, Takayuki Takimoto, Mayumi Suzuki, Izumi Nagatomo, Ken Sugimoto, Yuta Fujii, Hiroshi Kida, Kenji Mizuguchi, Mari Ito, Takashi Kijima, Hiromi Rakugi, Eisuke Mekada, Isao Tachibana, Atsushi Kumanogoh, Scientific reports,8(1) 5145-5145, 2018.03, Other

  • Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models., Morimura O, Minami T, Kijima T, Koyama S, Otsuka T, Kinehara Y, Osa A, Higashiguchi M, Miyake K, Nagatomo I, Hirata H, Iwahori K, Takimoto T, Takeda Y, Kida H, Kumanogoh A, Biochemical and biophysical research communications,488(4): 596–602, 2017.07, Other

  • Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas database., Higashiguchi M, Nagatomo I, Kijima T, Morimura O, Miyake K, Minami T, Koyama S, Hirata H, Iwahori K, Takimoto T, Takeda Y, Kida H, Kumanogoh A., FEBS Lett.,590(23):4275-4286, 2016.12, Papers